P58.42
Neonatal jaundice due to drugs or toxins given to newborn
Clinical Classification Guidelines
Medical Intelligence & Overview
Neonatal jaundice due to drugs or toxins is a condition that affects many newborns. It occurs when substances given to or taken by the mother before or during birth, or certain drugs administered directly to the infant, cause a build-up of bilirubin in the baby’s blood. This leads to jaundice, a yellow discoloration of the skin and eyes. Recognizing and managing this form of jaundice is essential for ensuring the health and safety of the newborn. This article explains what causes neonatal jaundice related to drugs and toxins, its symptoms, how it is diagnosed, and potential treatment options.
Causes & Symptoms
Clinical Causes: Maternal use of medications during pregnancy that cross the placenta and affect the fetus Administration of certain drugs directly to the newborn, such as antibiotics or sedatives Exposure to environmental toxins that are ingested or absorbed by the infant Use of substances that induce liver enzyme activity, leading to increased bilirubin production or decreased clearance Drug reactions or sensitivities causing hemolysis or liver dysfunction in the newborn
Key Symptoms: Yellowing of the skin and the sclera (white part of the eyes) When jaundice is severe, the yellow coloration may extend to the baby's face, trunk, and extremities Lethargy or decreased activity levels in some cases Poor feeding or difficulty breastfeeding Dark urine and pale stools in more advanced stages
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough assessment of the baby's health history and physical examination. Key diagnostic steps include: - Measuring serum bilirubin levels to ascertain the severity of jaundice - Blood tests to identify hemolytic anemia or other underlying blood conditions - Screening for metabolic or genetic disorders that may contribute - Reviewing maternal medication history for potential drug exposure - Monitoring the progression of jaundice and accompanying symptoms Imaging studies are rarely necessary but may be employed to rule out other causes of jaundice if indicated.
Treatment Protocols: Management of drug or toxin-induced neonatal jaundice aims to reduce bilirubin levels and address the underlying cause. Common approaches include: - Phototherapy: Exposure to specialized lights helps break down bilirubin in the skin - Discontinuation of any causative drugs or substances - Supportive care: Ensuring adequate hydration and nutrition to aid bilirubin clearance - Exchange transfusions may be needed in severe cases to rapidly lower bilirubin levels - Identifying and treating any associated health issues, such as hemolytic anemia It is important to carefully monitor bilirubin levels during treatment to prevent complications like kernicterus, a type of brain damage caused by very high bilirubin levels.
Clinical Advice & FAQs
Billing Guidance
Is P58.42 a billable ICD-10 code?
Yes, P58.42 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P58.42?
Clinical documentation must specify the nature of Neonatal jaundice due to drugs or toxins given to newborn and any associated comorbidities for accurate reporting.
Cite this Clinical Reference